Back to ABCL
MARSHALL WACE, LLP ABCL Position History
AbCellera Biologics Inc. • Healthcare
Quarters held
10
Latest value
$58.3M
Q3 2026
Peak value
$60.7M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $106K |
| Q2 2025 | $163K |
| Q3 2025 | $239K |
| Q1 2026 | $1.3M |
| Q2 2026 | $514K |
| Q2 2026 | $9.8M |
| Q2 2026 | $4.6M |
| Q3 2026 | $11.7M |
| Q3 2026 | $60.7M |
| Q3 2026 | $58.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $58.3M | 3.99M | — | — |
| Q3 2026 | $60.7M | 4.16M | — | — |
| Q3 2026 | $11.7M | 804.9K | — | — |
| Q2 2026 | $4.6M | 583.7K | — | — |
| Q2 2026 | $9.8M | 1.25M | — | — |
| Q2 2026 | $514K | 65.5K | — | — |
| Q1 2026 | $1.3M | 359.7K | — | — |
| Q3 2025 | $239K | 47.5K | — | — |
| Q2 2025 | $163K | 47.5K | — | — |
| Q1 2025 | $106K | 47.5K | — | — |
Other funds holding ABCL
$481.6M
$259.1M
$198.1M
$170.7M
$128.3M
$106.7M
$105.7M
$94.1M